Sun Pharma
June 23, 2026
Theater 1
Type: Company Presentation
Focus Area:
Dermatology
1. Global Presence: Operates in more than 100 countries
2. Diversified Business: Innovative medicines, branded generics, generics, and APIs
3. Emerging Markets: Operating at scale in more than 80 countries
4. Marketed products in Dermatology, Ophthalmology, and Oncology
5. Sun Pharmaceutical Industries Inc. has been operating in the US since 1996, with headquarters in Princeton, NJ
Company HQ City:
Princeton
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
1983
Lead Product in Development:
cosielimab
CEO
Richard Ascroft
Development Phase of Lead Product
Phase IV
Exchange
BSE
Ticker
SUNPHARMA.BO
When you expect your next catalyst update?
February 2027
What is your next catalyst (value inflection) update?
Organon acquisition closing (1Q 2027)
Primary Speaker
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}